These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6260667)

  • 1. Crystallization of pertussigen from Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1981 Jan; 31(1):495-9. PubMed ID: 6260667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.
    Munoz JJ; Arai H; Cole RL
    Infect Immun; 1981 Apr; 32(1):243-50. PubMed ID: 6260681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxic factors of Bordetella pertussis, with special reference to leukocytosis-promoting factor, histamine-sensitizing factor and hemagglutinins (author's transl)].
    Sato Y
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():164-83. PubMed ID: 194282
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isolation and purification of a preparation possessing leukocytosis-stimulating properties from pertussis bacteria].
    Trofimova NP; Demina AA; Igonina IuA; Dolomanova MS; Syresina GI
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):78-82. PubMed ID: 190830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions in the foot pads of mice induced by pertussigen and endotoxin from Bordetella pertussis.
    Munoz JJ; Robbins KE; Cole RL
    J Reticuloendothel Soc; 1980 Mar; 27(3):259-68. PubMed ID: 6245208
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
    Irons LI; MacLennan AP
    Biochim Biophys Acta; 1979 Sep; 580(1):175-85. PubMed ID: 232665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1973 Jun; 7(6):992-9. PubMed ID: 4351972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.
    Sewell WA; Munoz JJ; Vadas MA
    J Exp Med; 1983 Jun; 157(6):2087-96. PubMed ID: 6304228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of pertussis toxin correlates with pathogenesis in Bordetella species.
    Monack D; Munoz JJ; Peacock MG; Black WJ; Falkow S
    J Infect Dis; 1989 Feb; 159(2):205-10. PubMed ID: 2464653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial purification and some properties of the leukocytosis-promoting material from Bordetella pertussis.
    Sato Y; Arai H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):273-6. PubMed ID: 4099421
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological alterations of the adrenal gland following administration of histamine-sensitizing-factor of Bordetella pertussis.
    Kuwajima Y
    Osaka City Med J; 1980; 26(1):61-6. PubMed ID: 6267538
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis toxin: a tool for studying the regulation of adenylate cyclase.
    Sekura RD
    Methods Enzymol; 1985; 109():558-66. PubMed ID: 2859515
    [No Abstract]   [Full Text] [Related]  

  • 18. [The development of a new generation of pertussis vaccine].
    Chuprinina RP; Bychenko BD; Smirnov VD; Maksiutov RV; Eglit IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):89-94. PubMed ID: 2075771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of experimental allergic encephalomyelitis in mice with the aid of pertussigen from Bordetella pertussis.
    Munoz JJ; Mackay IR
    Cell Immunol; 1984 Jul; 86(2):541-5. PubMed ID: 6329525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.